Stock Analiz

InMode Ltd. INMD

Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2019 · data as of November 13, 2026

$13.27Market cap $763M
Open the interactive analysis →

InMode Ltd. (INMD) is a healthcare company listed in the US with a market value of about $763M. In the twelve months to September 30, 2026 it had revenue of $374M and net income of $75M, a net margin of 19.9%.

Its overall Stock Analiz score is 2.8 out of 5 (average). The strongest part is value (5/5); the weakest is future growth (0/5).

Key numbers: a P/E of 11.0, a price to free cash flow of 11.0, 5-year revenue growth of 12% a year, a 5-year average ROIC of 23%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 22% above the current price.

About InMode

InMode is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2019. Revenue went from $53M in 2017 to $370M in 2025, growth of about 27.4% a year. It was profitable in 9 of the last 9 years in our data. It spends 4% of revenue on research and development.

Score: 2.8 / 5

Value5/5
Future growth0/5
Track record3/5
Financial health5/5
Shareholder returns1/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 5-year revenue growth above 8% a year
  • 5-year average ROIC above 12%
  • Profitable 5 years in a row

Checks not passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year EPS growth above 10% a year
  • ROE above 15%
  • Pays a dividend

Valuation

P/E (TTM)11.0
Forward P/E10.2
P/FCF11.0
P/S2.0
P/B1.2
EV/EBITDA3.7
PEG1.10
Dividend yield0.00%
FCF yield9.1%
Shareholder yield16.7%
Intrinsic value vs. price+22%

Growth and quality

Revenue growth (1 yr)-6.2%
Revenue growth (5 yrs, per year)12.4%
EPS growth (5 yrs, per year)10.0%
FCF growth (3 yrs, per year)-22.4%
Net margin (5-yr avg.)38.6%
ROIC (5-yr avg.)22.6%
Profitable years (of last 10)9
Years paying a dividend—

Financials, last 9 years

Fiscal yearTTM202520242023202220212020201920182017
Revenue$374M$370M$395M$492M$454M$358M$206M$156M$100M$53M
Net income$75M$94M$181M$198M$162M$165M$75M$61M$22M$9M
Free cash flow$69M$84M$132M$176M$180M$174M$79M$62M$37M$14M
EPS (diluted)$1.21$1.63$3.15$3.44$2.81$2.87$1.31$1.06$0.39$0.15
Net margin19.9%25.3%45.9%40.2%35.6%46.1%36.4%39.1%22.3%16.5%
ROIC—10.5%12.5%22.4%28.3%39.1%28.1%33.1%51.4%41.4%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 3 analysts is $14.67, 11% above the current price; targets range from $14.00 to $15.00; the consensus rating is “Hold”; expected EPS is $1.32 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is InMode’s P/E ratio?

About 11.0, based on the last twelve months of diluted earnings per share (forward P/E about 10.2).

Is InMode stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 22% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does InMode pay a dividend?

Not currently.

Is InMode a good stock to buy?

We do not give buy or sell advice. InMode scores 2.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.